A review of the therapy of paraneoplastic neurologic syndromes

Journal of Neuro-Oncology

Volumn 41, Issue 2, 1999, Pages 181-194

  Das, Asha ^a   Hochberg, Fred H ^b,c   McNelis, Sean ^b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c Massachusetts General Hospital ^*  (United States)

Author keywords

Cancer associated neurologic disease; Immunosuppressive treatment

Indexed keywords

ANTINEOPLASTIC AGENT; IMMUNOGLOBULIN; NEUROTRANSMITTER; STEROID;

ARTICLE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; PARANEOPLASTIC SYNDROME; PLASMAPHERESIS; SYMPTOM;

HUMANS; IMMUNOSUPPRESSIVE AGENTS; NERVOUS SYSTEM DISEASES; PARANEOPLASTIC SYNDROMES; PLASMAPHERESIS; STEROIDS;

EID: 0032903578     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006133102928     Document Type: Article

References (211)

1. Berglund S, Eriksson M, von Eyben FE, Hellekant C, Mattsson W: Remission by chemotherapy of the Eaton-Lambert myasthenic syndrome in a patient with small cell bronchogenic carcinoma. Acta Med Scand 212: 429-432, 1982
2. Brennan LV, Cradock PR: Limbic encephalopathy as a nonmetastatic complication of oat cell lung cancer: its reversal after treatment of the primary lung lesion. Am J Med 75: 518-520, 1983
3. Cher L, Hochberg FH, Teruya J et al.: Therapy of paraneoplastic syndromes in six patients with Protein A column immunadsorption. Cancer 75: 1677-1683, 1995.
4. Cocconi G, Ceci G, Juvarra G, Minopoli MR, Cocchi T, Fiaccadori F, Lechi A, Boni P: Successful treatment of sub-acute cerebellar degeneration in ovarian carcinoma with plasmapheresis. Cancer 56: 2318-2320, 1985
5. Dalmau J, Posner JB: Neurologic paraneoplastic antibodies (anti-Yo; anti-Hu; anti-Ri): the case for a nomenclature based on antibody and antigen specificity. Neurol 44: 2241-2246, 1994
6. Schold SC, Cho ES, Somasundaram M, Posner JB: Subacute motor neuronopathy: a remote effect of lymphoma. Annals Neurol 5: 271-287, 1979
7. Anderson NE, Budde-Steffen C, Wiley RG, Thurman L, Rosenblum MK, Nadeau SE, Posner JB: A variant of the anti-Purkinje cell antibody in a patient with paraneoplastic cerebellar degeneration. Neurol 38: 1018-1025; 1988
8. Cairncross JG, Posner JB: Neurological complications of malignant lymphoma. Handbook of Clinical Neurology, Vinken and Bruyn, New York, 1980, part 39 pp 55
9. Hammack JE, Kimmel DW, O'Neill BP, Lennon VA: Paraneoplastic cerebellar degeneration: a clinical comparison of patients with and without Purkinje cell cytoplasmic antibodies. Mayo Clin Proc 65: 1423-1431, 1990
10. Furman JMR, Eidelman BH, Fromm GH: Spontaneous remission of paraneoplastic ocular flutter and saccadic intrusions. Neurology 38: 499-501, 1988
11. Ridley A, Kennard C, Scholtz CL, Büttner-Ennever SA, Summers B, Turnball A: Omnipause neurons in two cases of opsoclonus associated with oat cell carcinoma of the lung. Brain 110: 1699-1709, 1987
12. Luque FA, Furneaux HM, Ferziger R et al.: Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer. Annals Neurol 29: 241-251, 1991
13. Auth TL, Chodoff P: Transient cerebellar syndrome from extracerebral carcinoma. Neurol 7: 370-372, 1957
14. Kearsley JH, Johnson P, Halmagyi GM: Paraneoplastic cerebellar disease Remission with excision of the primary tumor. Arch Neurol 42: 1208-1210, 1985
15. Paone JP, Jeyasingham K: Remission of cerebellar dysfunction after pneumonectomy for bronchogenic carcinoma. New England J Medicine 302: 156, 1980
16. Enevoldson TP, Ball JA, McGregor JM: Resolution of a severe sensorimotor neuropathy following the resection of an associated asymptomatic gastric lymphoma. J Neurol Neurosurg Psych 53: 267-268, 1990
17. Fawcett DP, McBrien MP: Transitional cell carcinoma of the renal pelvis presenting with peripheral neuropathy. Brit J Urol 49: 202, 1977
18. Stephens TW, Rousgas A, Ghose MK: Pure motor neuropathy complicating carcinoma of bronchus removed after surgery. Brit J Diseas Chest 60: 107-109, 1966
19. Evans BK, Pagan C, Arnold T, Dropcho EJ, Oh SJ: Paraneoplastic motor neuron disease and renal cell carcinoma: improvement after nephrectomy. Neurol 40: 960-962, 1990
20. Smith B: Skeletal muscle necrosis associated with carcinoma. J Pathol 97: 207-289, 1969
21. Lowe BA, Mershon C, Mangalik A: Paraneoplastic neurologic syndrome in transitional cell carcinoma of the bladder. J Urol 147(2): 462-464, 1992
22. Berg BO, Ablin AR, Wang W, Skoglund R: Encephalopathy associated with occult neuroblastoma. J Neurosurg 41: 567-572, 1974
23. Davidson M, Tolentino, Sapir S: Opsoclonus and neuroblastoma. New England J Medicine 279: 948, 1968
24. Dyken P, Kolar O: Dancing eyes, dancing feet: infantile polymyoclonia. Brain 91: 305-320, 1968
25. Solomon GE, Chutorian AM: Opsoclonus and occult neuroblastoma. New England J Medicine 279: 475-477, 1968
26. Chalk CH, Murray NMF, Newsom-Davis J, O'Neill JH, Spiro SG: Response of the Lambert-Eaton myasthenic syndrome to treatment of associated small cell lung cancer. Neurol 40: 1552-1556, 1990
27. Clamon GH, Evans WK, Shepherd FA, Humphrey JG: Myasthenic syndrome and small cell cancer of the lung: variable response to antineoplastic therapy. Arch Internal Medicine 144: 999-1000, 1984
28. Park DM, Johnson RH, Crean GP, Robinson JF: Orthostatic hypotension in bronchial carcinoma. Brit Med J 3: 510-511, 1972
29. Jablecki C: Lambert-Eaton myasthenic syndrome. Muscle Nerve 7: 250-257, 1984
30. Jenkyn LR, Brooks PL, Forcier RJ, Maurer LH, Ochoa J: Remission of the Lambert-Eaton syndrome and small cell anaplastic carcinoma of the lung induced by chemotherapy and radiotherapy. Cancer 46: 1123-1127, 1980
31. Kalter S, Dhingra HM, Farha P: Primary therapy for small cell lung cancer reversing the Eaton-Lambert syndrome. South Med J 78: 197-198, 1985
32. Oh SJ: SFEMG improvement with remission in the cancer associated Lambert-Eaton myasthenic syndrome. Muscle Nerve 12: 844-848, 1989
33. Markham M, Abeloff MD: Small cell lung cancer and limbic encephalitis. Ann Internal Med 96: 785, 1982
34. Anderson NE, Rosenblum MK, Graus F, Wiley RG, Posner JB: Autoantibodies in paraneoplastic syndromes associated with small cell lung cancer. Neurol 38: 1391-1398, 1988
35. Anderson NE, Budde-Steffen C, Rosenblum M et al.: Opsoclonus, myoclonus, ataxia, and encephalopathy in adults with cancer: a distinct paraneoplastic syndrome. Medicine 67: 100-109, 1988
36. Ferrari P, Federico M, Grimaldi LME, Silingardi V: Stiffman syndrome in a patient with Hodgkin's disease. An unusual paraneoplastic syndrome. Haematologica 75: 570-572, 1990
37. Khandekar JD, Oyer D, Miller HJ, Vick NA: Neurologic involvement in glucagonoma syndrome. Response to combination chemotherapy with 5-fluorouracil and streptozotocin. Cancer 44: 2014-2016, 1979
38. Lambrecht ER, van der Loos TLJM, van der Eerden AHAM: Retrobulbar neuritis as the first sign of glucagonoma syndrome. Internat Ophthalmol 11: 13-15, 1987
39. Dalmau J, Graus F, Rosenblum MK, Posner JB: Anti-Huassociated paraneoplastic encephalomyelitis/sensory neuronopathy: a clinical study of 71 patients. Medicine 71: 59-72, 1992
40. Ingram PA, Davis GR, Schwartz MS, Traub M, Newland AC, Swash M: Cancer-associated myasthenic (Eaton-Lambert) syndrome: distribution of abnormality and effect of treatment. J Neurol, Neurosurg Psych 47: 806-812, 1984
41. Sapra R, Armentrout S, Margileth D, Opfell R: Subacute cerebellar degeneration in Hodgkin's disease (HD): successful treatment with plasmapheresis. Proc Am Ass Cane Res 22: 511, 1981
42. Fisher PG, Wechsler DS, Singer HS: Anti-Hu antibody in a neuroblastoma-associated paraneoplastic syndrome. Ped Neurol 10: 309-312, 1994
43. Case Records of the Massachusetts General Hospital. (Case 9-1988) New England J Medicine 318: 563-570, 1988
44. Herishanu Y: Immunological abnormalities in opsoclonus cerebellopathy. Neuro-Ophthalmol 5: 271-275, 1985
45. Nausieda PA, Tanner CM, Weiner WJ: Opsoclonic cerebellopathy. A paraneoplastic syndrome responsive to thiamine. Arch Neurol 38: 780-781, 1981
46. Masson C, Prier S, Benoit C, Henin D, Masson M, Cambier J: Amnesia and Stiffman syndrome. Manifestations disclosing paraneoplastic encephalomyelitis. Anal Medecine Intern 138: 502-505, 1987
47. Folli F, Solimena M, Cofiell R, Austoni M, Tallini G, Fasetta G, Bates D, Cartlidge N et al. Autoantibodies to a 128-kd synaptic protein in three women with the stiff-man syndrome and breast cancer. New England J Medicine 328: 546-551, 1993
48. Stoll DB, Lublin F, Brodovsky H, Laucius F, Petchefsky A, Cooper H: Association of subacute motor neuronopathy with thymoma. Cancer 54: 770-772, 1984
49. Roobal TH, Kazzaz BA, Vecht CJ: Segmental rigidity and spinal myoclonus as a paraneoplastic syndrome. J Neuro Neurosurg Psych 50: 628-631, 1987
50. McEvoy KM, Windebank AJ, Daube JR, Low PA: 3,4-Diaminopyridine in the treatment of Lambert-Eaton myasthenic syndrome. New England J Medicine 321: 1567-1571, 1989
51. Vincent D, Dubas F, Hauw JJ, Godeau P, Lhermitte F, Buge A, Castaigne P: Nerve and muscle microvasculitis in peripheral neuropathy: a remote effect of cancer? J Neurol Neurosurg Psych 49: 1007-1010, 1986
52. Oh SJ, Dropcho EJ: Steroid-responsive paraneoplastic encephaloneuropathy. Neurol 40(suppl 1): 246, 1990
53. Anderson NE, Budde-Steffen C, Wiley RG, Thurman L, Rosenblum MK, Nadeau SE, Posner JB: A variant of the anti-Purkinje cell antibody in a patient with paraneoplastic cerebellar degeneration. Neurol 38: 1018-1025, 1988
54. Horwich MS, Cho L, Porro RS, Posner, JB: Subacute sensory neuropathy: a remote effect of carcinoma. Ann Neurol 2: 7-19, 1977
55. Victor M, Ferrendelli JA: The nutritional and metabolic diseases of the cerebellum. Clinical and pathological aspects. In: Fields WS, Willis WD Jr., Eds. The cerebellum in health and disease, Chapter 16. St. Louis: Warren H. Green, Inc., 1970: 412-449
56. Lachance DH, O'Neill BP, Harper CM, Banks PM, Cascino TL: Paraneoplastic brachial plexopathy in a patient with Hodgkin's disease. Mayo Clinic Proceedings 66: 97-101, 1991
57. Torvik A, Berntzen AE: Necrotizing vasculitis without visceral involvement. Post-mortem examination of three cases of affection of skeletal muscles and peripheral nerves. Acta Med Scand 184: 69-77, 1968
58. Oh SJ, Slaughter R, Harrell L: Paraneoplastic vasculitic neuropathy: a treatable neuropathy. Muscl Nervel 4: 152-156, 1991
59. Graus F, Vega F, Delattre JY, Bonaventura I, Rene R, Arbaiza D, Tolosa E: Plasmapheresis and antineoplastic treatment in CNS paraneoplastic syndromes with antineuronal autoantibodies. Neurol 42(3Pt1): 536-540, 1992
60. Vega F, Graus F, Chen QM, Schüller E, Poisson M, Delattre JY: Intravenous (iv) immunoglobulin therapy in paraneoplastic neurologie syndromes (pns) with antineuronal antibodies. Neurol 44(suppl 2): 157, 1994
61. Horwich MS, Cho L, Porro RS, Posner, JB: Subacute sensory neuropathy: a remote effect of carcinoma. Ann Neurol 2: 7-19, 1977
62. Sagar HJ, Read DJ: Subacute sensory neuropathy with remission: an association with lymphoma. J Neurol Neurosurg Psych 45: 83-85, 1982
63. Ambler Z, Janda J: Subacute cerebral atrophy in Hodgkin's disease. Cs Neurol Neurochir 46/79: 36-40, 1983
64. Mitchell WG, Snodgrass SR: Chronic relapsing steroid-sensitive ataxic syndrome in children with ganglioneuroblastoma. Ann Neurol 24: 352, 1988
65. Peterson K, Rosenblum MK, Kotanides H, Posner JB: Paraneoplastic cerebellar degeneration. A clinical analysis of 55 anti-Yo antibody-positive patients. Neurol 42: 1931-1937, 1992
66. Tsukamoto T, Yamamoto H, Iwasaki Y, Yoshie O, Terunuma H, Suzuki H: Antineural antibodies in patients with paraneoplastic cerebellar degeneration. Arch Neurol 46: 1225-1229, 1989
67. Froissart M, Mizon JP, Morcamp D, Demay JP. Atrophie cérébelleuse subaiguë paranéoplasique au cours d'une maladie de Hodgkin. Nouv Presse Med 323: 660-661, 1976
68. Gonzalez del Val R, Garcia Arroyo R, Villaneueva JA, Moro E: Subacute paraneoplastic cerebellar degeneration in microcytic carcinoma of the lung. Presentation of two cases. Medicine Clinica 99: 701-704, 1992
69. Greenlee JE, Lipton HL: Anticerebellar antibodies in serum and cerebrospinal fluid of a patient with oat cell carcinoma of the lung and paraneoplastic cerebellar degeneration. Ann Neurol 19: 82-85, 1986
70. Mintz BJ, Sirota DK: A case report of neurologic improvement following treatment of paraneoplastic cerebellar degeneration. Mt Sinai J Med 60: 163-164, 1993
71. Rewcastle NB: Subacute cerebellar degeneration with Hodgkin's disease. Arch Neurol 9: 407-413, 1963
72. Greenberg HS: Paraneoplastic cerebellar degeneration: a clinical and CT study. J Neuro-Oncol 2: 377-382, 1984
73. Royal W, Galasko DR, McKhann GM, Cunningham JM, Dropcho EJ: Clinical course, immunologic, and biochemical features of a patient with paraneoplastic cerebellar degeneration. Neurol 37(suppl 1): 305, 1987
74. Tsukamoto T, Yoshie O, Tada K, Iwasaki Y: Anti-Purkinje cell antibody producing B-cell lines from a patient with paraneoplastic cerebellar degeneration. Arch Neurol 111: 833-837, 1987
75. Counsell CE, McLeod M, Grant R: Reversal of subacute paraneoplastic cerebellar degeneration with intravenous immunoglobulin. Neurol 44: 1184-1185, 1994
76. Felician O, Renard JL, Vega F, Créange A, Chen QM, Bequet B, Delattre JY: Paraneoplastic cerebellar degeneration with anti-Yo antibody in a man. Neurol 45: 1226-1227, 1995
77. Moll JW, Henzen-Logmans SC, van der Meché FGA, Vecht CHJ: Early diagnosis and intravenous immune globulin therapy in paraneoplastic cerebellar degeneration. J Neurol Neurosurg Psych 56: 112-115, 1993
78. Roberts HJV: A case of spino-cerebellar degeneration associated with carcinoma of the prostate. Med J Australia 1: 391-393, 1967
79. Keltner JL, Roth AM, Chang RS: Photoreceptor degeneration. A possible autoimmune disorder. Arch Ophthalmol 101: 564-569, 1983
80. Klingele TG, Burde RM, Rappazzo JA, Isserman MJ, Burgess D, Kantor O: Paraneoplastic retinopathy. J Clin Neuro-Ophthalmol 4: 239-245, 1984
81. Jacobson DM, Thirkill CE, Tipping SJ: A clinical triad to diagnose paraneoplastic retinopathy. Ann Neurol 28: 162-167, 1991
82. Keltner JL, Thirkill CE, Tyler NK, Roth AM: Management and monitoring of cancer-associated retinopathy. Arch Ophthalmol 110: 48-53, 1992
83. Kilgo GR, Schwartz GM: Opsoclonus: J Clin Neuro-Ophthalmol 4: 109-119, 1984
84. Lago A, Burguera JA, Vilchez JJ et al. Opsoclonic cerebellar disease. A paraneoplastic syndrome sensitive to chloromethiazole. Anal Medicine Interna 6: 260-262, 1992
85. Norris FH Jr, Engele WK: Carcinomatous amyotrophic lateral sclerosis. In: Brain WR, Norris FH Jr, eds. The remote effects of cancer on the nervous system. New York: Grune & Stratton, 1965: 24-41
86. Peters HA, Clatanoff DV: Spinal muscular atrophy secondary to macroglobulinemia. Neurol 18: 101-108, 1968
87. Sheinman BD, Gawler J: Opsoclonus and polymyoclonia complicating oat-cell carcinoma of the bronchus. Postgrad Med J 58: 704-705, 1982
88. McLoughlin J, Gingell JC, Harper G et al. Cerebellar manifestations of prostatic carcinoma. Postgrad Med J 86: 584-586, 1992
89. Reddy RV, Vakili ST: Midbrain encephalitis as a remote effect of a malignant neoplasm. Arch Neurol 38: 781-782, 1981
90. Glantz MJ, Biran H, Myers ME et al. The radiographic diagnosis and treatment of paraneoplastic central nervous system disease. Cancer 73: 168-175, 1994
91. Escudero D, Barnadas A, Codina M, et al. Anti-Ri associated paraneoplastic neurologic disease without opsoclonus in a patient with breast cancer. Neurol 43: 1605-1606, 1993
92. Piccolo G, Cosi V: Stiff-man syndrome, dysimmune disorder, and cancer. Ann Neurol 26: 105, 1989
93. Eekhoff JL: Remission of a paraneoplastic cerebellar degeneration. Clin Neurol Neurosurg 87: 133-134, 1985
94. Vollmer J, Ferbert A, Thron A: Paraneoplastic limbic encephalitis. A case report. Nervenarzt 64: 659-662, 1993
95. Croft PB, Wilkinson M: The course and prognosis in some types of carcinomatousneuromyopathy. Brain 92: 1-8, 1969
96. Leger JM, Bachoud-Levi AC, Eymard B et al. Syndrome myasthenique paranéoplasique. Revue Neurol 149: 485-488, 1993
97. Brain L, Croft PB, Wilkinson M: Motor neurone disease as a manifestation of neoplasm. Brain 88: 479-500, 1965
98. Bruyland M, Van Belle S, Schallier D et al. Good response of a paraneoplastic neuromyopathy to cyclophosphamide. Cancer Treat Rep 68: 787-789, 1984
99. Johnson PC, Rolak LA, Hamilton RH et al. Paraneoplastic vasculitis of nerve: a remote effect of cancer. Ann Neurol 5: 437-444, 1979
100. Takigawa N, Ohnoshi T, Ueoke H et al. A case of small cell bronchogenic carcinoma accompanied by polyneuropathy and SIADH. Jap J Thoracic Dis 31: 346-351, 1993
101. Twijnstra A, Verschuuren J, Byrne TN et al. Prolonged or remitting anti-Hu associated paraneoplastic sensory neuronopathy (PSN) and encephalomyelitis (PEM). Neurol 45: A321, 1995
102. Dodgson MCH, Hoffman HL: Sensory neuropathy associated with carcinoma of the esophagus: report of a case. Ann Internal Med 38: 130-135, 1953
103. Jaeckle KA, Graus F, Houghton AN et al.: Autoimmune response of patients with paraneoplastic cerebellar degeneration to a Purkinje cell cytoplasmic protein antigen. Ann Neurol 18: 592-600, 1985
104. Younger DS, Rowland LP, Latov N et al. Lymphoma, motor neuron diseases and amyotrophic lateral sclerosis. Ann Neurol 29: 78-86, 1991
105. Toupet M, deGramont A, Bacri D et al. Le flutter-opsoclonie. Revue Neurol 138: 219-239, 1982
106. Carr I: The Ophelia syndrome: memory loss in Hodgkin's disease. Lancet 1: 844-845, 1982
107. Brownell B, Oppenheimer DR, Hughes JT: The central nervous system in motor neurone disease. JNNP 30: 338-357, 1970
108. Farrelly C, Daneman A, Chan HS et al. Occult neuroblastoma presenting with opsomyoclonus: utility of computed tomography. AJR 142: 807-810, 1984
109. Hetzel DJ, Stanhope CR, O'Neill BP et al. Gynecologic cancer in patients with subacute cerebellar degeneration predicted by anti-Purkinje cell antibodies and limited in metastatic volume. Mayo Clinic Proc 65: 1558-1563, 1990
110. Alanis BF, Flanagan JF: Myopathy and hypercalcemia occurring with carcinoma of the kidney. JAMA 171: 2076-2080, 1959
111. Croft PB, Urich H, Wilkinson M: Peripheral neuropathy of sensorimotor type associated with malignant disease. Brain 90: 31-66, 1967
112. Dropcho EJ, Payne R: Paraneoplastic opsoclonusmyoclonus associated with medullary thyroid cancer and review of the literature. Arch Neurol 43: 410-415, 1986
113. Ahern GL, O'Connor M, Dalmau J et al. Paraneoplastic temporal lobe epilepsy with testicular neoplasm and atypical amnesia. Neurol 44: 1270-1274, 1994
114. Ahmed MN, Carpenter S : Autonomic neuropathy and carcinoma of the lung. Canadian Med Ass J 113: 410-412, 1975
115. Alessi D: Lesioni parenchimatose del cervelleto da carcinoma uterino (gliossi carcinotossica?). Riv Pathol Nerv Ment 55: 148-174, 1940
116. Bakheit AMO, Kennedy PGE, Behan PO: Paraneoplastic limbic encephalitis: clinico-pathological correlations. J Neurol Neurosurg Psych 12: 1084-1088, 1990
117. Bateman DE, Weller RO, Kennedy P: Stiffman syndrome: a rare paraneoplastic disorder. J Neurol Neurosurg Psych 53: 695-696, 1990
118. Batson OA, Fantle DM, Stewart JA: Paraneoplastic encephalomyelitis. Dramatic response to chemotherapy alone. Cancer 69: 1291-1293, 1992
119. Bellur SN: Opsoclonus: its clinical value. Neurol 25: 502-507, 1975
120. Beresford OD, McLetchie NGB: Hodgkin's disease: an unusual case with spinal symptoms. British Med J 2: 136-137, 1948
121. Boghen D, Sebag M, Michaud J: Paraneoplastic optic neuritis and encephalomyelitis. Ann Neurol 45: 353-358, 1988
122. Brain L, Wilkinson M: Subacute cerebellar degeneration associated with neoplasms. Brain 88: 465-478, 1965
123. Brashear HR, Li L, Herr JC: Antineuronal antibody in two patients with paraneoplastic opsoclonus-ataxia. Neurol 42(suppl 3): 457, 1992
124. Bray PF, Ziter FA, Lahey E, Meyers GG: The coincidence of neuroblastoma and acute cerebellar encephalopathy. J Pediatrics 75: 983-990, 1969
125. Brazis PW, Biller J, Fine M, Palacios E, Pagano RJ: Cerebellar degeneration with Hodgkin's disease. Computed tomography correlation and literature review. Arch Neurol 38: 253-256, 1981
126. Buchanan DS, Malamud N: Motor neuron disease with renal cell carcinoma and postoperative neurologic remission. Neurol 23: 891-894, 1973
127. Buchanan TAS, Gardiner TA, Archer DB: An ultrasound study of retinal photoreceptor degeneration associated with bronchial carcinoma. Amer J Ophthalmol 97: 277-287, 1984
128. Burton GV, Bullard DE, Walther PJ, Burger PC: Paraneoplastic limbic encephalopathy with testicular carcinoma. A reversible neurologic syndrome. Cancer 62: 2248-2251, 1988
129. Carr-Locke DL: Autonomie neuropathy and inappropriate secretion of antidiuretic hormone. J American Med Ass 241: 2298, 1979
130. Case Records of the Massachusetts General Hospital 46421. New England J Medicine 263: 804-808, 1960
131. Chalk CH, Widebank AJ, Kimmel DW, McManis PG: The distinctive clinical features of paraneoplastic sensory neuronopathy. Canadian J Neurol Sci 19: 346-351, 1992
132. Chiappa KH, Young RR: A case of paracarcinomatous pandysautonomia. Neurol 23: 423, 1973
133. Corsellis JAN, Goldberg GJ, Norton AR: 'Limbic encephalitis' and its association with carcinoma. Brain 91: 481-496, 1968
134. Croft PB, Henson RA, Urich H, Wilkinson PC: Sensory neuropathy with bronchial carcinoma: a study of four cases showing serological abnormalities. Brain 88: 501-514, 1965
135. Dalmau J, Furneaux HM, Rosenblum MK, Graus F, Posner JB: Detection of the anti-Hu antibody in specific regions of the nervous system and tumor from patients with paraneoplastic encephalomyelitis/sensory neuronopathy. Neurol 41: 1757-1764, 1991
136. Dansey RD, Hammond-Tooke GD, Lai K, Bezwoda WR: Subacute myelopathy: an unusual paraneoplastic complication of Hodgkin's disease. Med Ped Oncol 16: 284-286, 1988
137. Darnell RB, DeAngelis LM: Regression of small cell lung carcinoma in patients with paraneoplastic neuronal antibodies. Lancet 341: 21-22, 1993
138. Digre KB: Opsoclonus in adults. Report of three cases and review of the literature. Arch Neurol 43: 1165-1175, 1986
139. Dorfman LJ, Forno LS: Paraneoplastic encephalomyelitis. Acta Neurologica Scandinavica 48: 556-574, 1972
140. Downie AW: Subacute cerebellar atrophy following carcinoma of the ovaries. Proc Royal Soc Medicine 48: 181, 195
141. Dropcho EJ, Kline LB, Riser J: Antineuronal (anti-Ri) antibodies in a patient with steroid-responsive opsoclonusmyoclonus. Neurol 43: 207-211, 1993
142. Dyck PJ, Bailey AA, Olszewski J: Carcinomatous neuromyopathy: a case of sensory neuropathy and myopathy with onset three and one-half years before clinical recognition of the bronchogenic carcinoma. Canadian Med Ass J 79: 913-916, 1958
143. Ellenberger C, Netsky MG: Anatomic basis and diagnostic value of opsoclonus. Arch Ophthalm 83: 307-310, 1970
144. Furneaux HM, Reich L, Posner JB: Autoantibody synthesis in the central nervous system of patients with paraneoplastic syndromes. Neurol 40: 1085-1091, 1990
145. Gennaula CP, Eidelman BH: Anti-Ri paraneoplastic syndrome in association with primary lung carcinoma. Neurol 451: 1417, 1995
146. Gerling GM, Woolsey RM: Paraneoplastic motor neurone disease. Mo Med 64: 503-506, 1967
147. Graus F, Cordon-Cardo C, Cho ES, Posner JB: Opsoclonus and oat cell carcinoma of the lung: lack of evidence for anti-CNS antibodies. Lancet 1: 1479, 1984
148. Graus F, Cordon-Cardo C, Posner JB: Neuronal antinuclear antibody in sensory neuronopathy from lung cancer. Neurol 35: 538-543, 1985
149. Graus F, Elkon K, Cordon-Cardo C, Posner JB: Sensory neuronopathy and small cell lung cancer: antineuronal antibody that also reacts with the tumor. Amer J Med 80: 45-52, 1986
150. Graus F, Abos J, Roquer J, Mazzara R, Pereira A: Effect of plamapheresis on serum and CSF autoantibody levels in CNS paraneoplastic syndromes. Neurol 40: 1621-1623, 1990
151. Greco FA, Kolins J, Rajjoub RK, Brereton HD: Hodgkin's disease and granulomatous angiitis of the central nervous system. Cancer 38: 2027-2032, 1976
152. Greenlee JE, Brashear HR: Antibodies to cerebellar purkinje cells in patients with paraneoplastic cerebellar degeneration and ovarian carcinoma. Ann Neurol 14: 609-613, 1983
153. Greenlee JE, Brashear HR, Rodnitzsky RL, Corbett JJ, Digre KB: Fall in antineuronal antibody titers and improvement of neurologic deficits following tumor removal in paraneoplastic cerebellar degeneration. Neurol 36(suppl 1): 334, 1986
154. Grisold W, Lutz, Wolf D: Necrotizing myelopathy associated with acute lymphoblastic leukemia. Case report and review of the literature. Acta Neuropath (Berl) 49: 231-235, 1983
155. Halperin JJ, Richardson EP, Ellis J, Ross JS, Ewing SH: Paraneoplastic encephalomyelitis and neuropathy. Arch Neurol 36: 773-775, 1981
156. Hammack JE, Kotanides H, Rosenblum MK, Posner JB: Paraneoplastic cerebellar degeneration. II clinical and immunologic findings in 21 patients with Hodgkin's disease. Neurol 42: 1938-1943, 1992
157. Hawley RJ, Cohen MH, Saini N, Armbrustmacher VW: The carcinomatous neuromyopathy of oat cell lung cancer. Ann Neurol 7: 65-72, 1980
158. Heathfield KWG, Turner JWA: Peripheral neuritis and carcinoma of bronchus. Proc Royal Soc Med 42: 229-30, 1982
159. Henson RA, Hoffman HL, Urich H: Encephalomyelitis with carcinoma. Brain 88: 449-464, 1965
160. Hersh B, Dalmau J, Dangond F, Gultekin S, Geller E, Wen PY: Paraneoplastic opsoclonus-myoclonus associated with anti-Hu antibody. Neurol 44: 1754-1755, 1994
161. Holmes A, Kilpatrick C, Proietto J, Green MD: Reversal of a neurologic paraneoplastic syndrome with octreotide (sandostatin) in a patient with glucagonoma. Amer J Med 91: 434-436, 1991
162. Horwich L, Buxton PH, Ryan GMS: Cerebellar degeneration with Hodgkin's disease. J Neurol Neuro Psych 29: 45-51, 1966
163. Hughes M, Ahern V, Kefford R, Boyages J: Paraneoplastic myelopathy at diagnosis in a patient with pathologic stage 1A Hodgkin disease. Cancer 70: 1598-1600, 1992
164. Ivy HK: Renal sodium loss and bronchogenic carcinoma. Arch Inter Med 108: 115-123, 1961
165. Kornguth SE, Klein R, Appen R, Choate J: Occurrence of anti-retinal ganglion cell antibodies in patients with small cell carcinoma of the lung. Cancer 50: 1289-1913, 1982
166. Lang B, Newsom-Davis J, Wray D, Vincent A: Autoimmune aetiology for myasthenic (Eaton-Lambert) syndrome. Lancet 2: 224-226, 1981
167. Lechi A, Tedeschi F, Terzano MG, Trabattoni G: Opsoclonus and myoclonus in malignant disease. A case report. Acta Neurologica (Napoli) 5: 205-209, 1983
168. Lester EP, Feld E, Kinzie JJ, Wollmann R: Necrotizing myelopathy complicating Hodgkin's disease. Arch Neurol 36: 583-585, 1979
169. Malamud N, Hirano A: Atlas of neuropatholgy, 2nd ed., Berkeley-Los Angeles-London: Univ of California Press, 302-303, 1974
170. Mancall EL, Rosales RK: Necrotizing myelopathy associated with visceral cancer. Brain 87: 629-636, 1964
171. McCaughey WTE, Milar JHD: Nervous degeneration in malignant disease. Lancet 2: 365-366, 1955
172. McDonald W: Cortical cerebellar degeneration with ovarian cancer. Neurol 11: 328-334, 1961
173. Mitchell DM, Olczak SA: Remission of a syndrome indistinguishable from motor neurone disease after resection of bronchial carcinoma. Brit Med J 2: 176-177, 1979
174. Ogilvie H: Large intestine colic due to sympathetic deprivation. A new clinical syndrome. Brit Med J 2: 671-673, 1948
175. Oh SJ: The Eaton-Lambert syndrome. Arch Neurol 27: 91-94, 1972
176. Ohnishi A, Ogawa M: Preferential loss of large lumbar primary sensory neurons in carcinomatous sensory neuropathy. Ann Neurol 20: 102-104, 1986
177. Ojeda VJ: Necrotizing myelopathy associated with malignancy. A clinicopathologic study of two cases and review of the literature. Cancer 53: 1115-1123, 1984
178. Peacock A, Dawkins K, Rushworth G: Motor neurone disease associated with bronchial carcinoma? Brit Med J 2: 499-500, 1979
179. Pillay N, Gilber JJ, Brown JD: Internuclear ophthalmoplegia and 'optic neuritis'. Paraneoplastic effects of bronchial carcinoma. Neurol 34: 788-791, 1984
180. Prinz RA, Porenti AJ, Dorsch TR et al. Glucagon producing islet cell tumors of the pancreas. Proc Inst Med Chic 32: 133, 1979
181. Recine U, Longhi C, Pelosio A, Massine R: An unusually severe subacute motor neuronopathy in Hodgkin's disease. Acta Haematologica 71: 135-138, 1984
182. Renullo JFC, Pineada R, Gaulio AR: Cutaneous melanoma-associated retinopathy with retinal periphlebitis. Arch Ophthalmol 113: 854-855, 1995
183. Ross AT, Zeman W: Opsoclonus, occult carcinoma, and chemical pathology in dentate nuclei. Arch Neurol 17: 546-551, 1967
184. Rowland LP, Schneck SA: Neuromuscular disorders associated with malignant neoplastic disease. J Chronic Diseases 16: 777-795, 1963
185. Sawyer RA, Selhorst JB, Zimmerman LE, Hoyt WE: Blindness caused by photoreceptor degeneration as a remote effect of cancer. Amer J Ophthalmol 81: 606-613, 1976
186. Schlake HP, Husstedt IW, Grotemeyer KH, Pötter R: Paraneoplastic subacute cerebellar degeneration in Hodgkin's disease. Report of three cases and review of the literature. Clin Neurol Neurosurg 91: 329-335, 1989
187. Schuffler MD, Baird HW, Fleming CR, Bell CE, Bouldin TW, Malagelade JR, McGill DB, LeBauer SM, Abram M, Lowe J: Intestinal Pseudo-obstruction as the presenting manifestation of small cell carcinoma of the lung. Ann Inter Med 98: 129-134, 1983
188. Sieben GM, DeReuck J, De Bruyne JC, Eecken HMV: Subacute necrotic myelopathy. Its appearance eight years after cure of breast cancer. Arch Neurol 38: 775-777, 1981
189. Siemsen JK, Meister L: Bronchogenic carcinoma associated with severe orthostatic hypotension. Ann Inter Med 58: 669-676, 1963
190. Sodhi N, Camilleri M, Camoriano JK, Low PA, Fealey RD, Perry ML: Autonomic function and motility in intestinal pseudoobstruction caused by paraneoplastic syndrome. Digest Dis Sci 34: 1937-1942, 1989
191. Steven MM, Mackay IR, Carnegie PR, Bhathal PS, Anderson R: Cerebellar cortical degeneration with ovarian carcinoma. Postgrad Med J 58: 47-51, 1982
192. Tandon R, Walden M, Falcon S: Catatonia as a manifestation of paraneoplastic encephalopathy. J Clin Psych 49: 121-122, 1988
193. Telander RL, Smithson WA, Grover RV: Clinical outcome in children with acute cerebellar encephalopathy and neuroblastoma. J Ped Surg 24: 11-14, 1989
194. Thirkill CE, Roth AM, Keltner JL: Cancer-associated retinopathy. Arch Ophthalmol 105: 372-375, 1987
195. Thirkill GE, Fitzgerald P, Sergott RC, Roth AM, Tyler NK, Keltner JL: Cancer associated retinopathy (CAR syndrome) with antibodies reacting with retinal, optic nerve, and cancer cells. New Engl J Med 321: 1589-1594, 1989
196. Thomas JP, Shields R. Associated autonomic dysfunction and carcinoma of the pancreas. Brit Med J 4: 32, 1970
197. Trotter JL, Hendin BA, Osterland CK. Cerebellar degeneration with Hodgkin disease: an immunological study. Arch Neurol 33: 660-661, 1976
198. Tsapatsaris N, Wanger SL, Steinberg D: Cerebellar degeneration with Hodgkin's disease. Arch Inter Med 139: 829-830, 1979
199. Tsukamoto T, Mochizuki R, Mochizuki H, Noguchi M, Kayama H, Hiwatashi M, Yamamoto T: Paraneoplastic cerebellar degeneration and limbic encephalitis in a patient with adenocarcinoma of the colon. J Neurol Neurosurg Psych 56: 713-716, 1993
200. Turner JWA: Peripheral neuritis and carcinoma of the bronchus. Proc Royal Soc Med 45: 229, 1952
201. Valbonesi M, Montari F, Masconi L: A critical approach to therapeutic apheresis in the management of inflammatory dysimmune polyneuropathy. Haematologica 18: 33-43, 1985
202. Valldeoriole F, Vega F, Rene R, Pou A, Roquer J, Delattre JY, Graus F: Neurologie syndromes associated with anti Hu antibody. Study of 24 patients. Medicina Clinica 99: 361-410, 1992
203. Valtysson G, Fisher-Beckfield P, Carbone PP: Cerebellar degeneration with Hodgkin's disease. Cane J Clin 29: 246-249, 1979
204. Vick N, Schulman S, Dau P: Carcinomatous cerebellar degeneration, encephalomyelitis and sensory neuropathy (radiculits). Neurol 19: 425-444, 1969
205. Walton JN, Tomlinson BE, Pearce GW: Subacute 'poliomyelitis' and Hodgkin's disease. J Neurol Sci 6: 435-445, 1968
206. Waterhouse DM, Natale RB, Cody RL: Breast cancer and paraneoplastic cerebellar degeneration. Cancer 68: 1835-1841, 1991
207. Waterston JA, Gilligan BS : Paraneoplastic optic neuritis and external ophthalmoplegia. Austral New Zealand J Med 16: 703-704, 1986
208. Weissman DE, Gottschall JL: Complete remission of paraneoplastic sensorimotor neuropathy: a case associated with small cell lung cancer responsive to chemotherapy, plasma exchange, and radiotherapy. J Clin Apher 5: 3-6, 1989
209. Wessel K, Diener HC, Schroth G, Dichgan J: Paraneoplastic cerebellar degeneration associated with Hodgkin's disease. J Neurol 235: 122-124, 1987
210. Wiley RG, Anderson NE, Hollister A, Posner J: Autonomic insufficiency in the paraneoplastic neuropathy of oat cell carcinoma. Neurol 38(suppl 1): 115, 1988
211. Wurzer H, Brandstätter G, Harnoncourt K, Kullnig P, Kleinert R: Paraneoplastic polymyositis associated with a renal carcinoma. J Inter Med 234: 521-524, 1993